Supplement Retail Expansions
Niagen Bioscience has expanded the retail availability of its Tru Niagen product line, including Tru Niagen Beauty, into GNC and Sam's Club stores across 44 states. This move signifies a broader trend of science-backed healthy aging supplements transitioning from niche wellness shops to mainstream retail, making advanced cellular health products more accessible to everyday consumers. The expansion highlights growing consumer interest in NAD+ support for cellular energy, mitochondrial function, and DNA repair, as well as the increasing market for beauty-from-within ingestible supplements.
Got prescriptions at Kroger? You may qualify for payment in $17 million proposed settlement
Kroger has reached a proposed $17 million settlement in a class action lawsuit alleging the grocer overcharged customers for generic prescription medications. Customers who filled prescriptions at Kroger-owned stores using insurance between December 9, 2018, and August 23, 2026, may qualify for a payment. Claims can be filed online until December 21, 2026, with payouts calculated proportionally based on the amount paid by the claimant and the total number of authorized claims.
Cencora stock initiated at Sector Perform by RBC Capital with $330 target
RBC Capital has initiated coverage on Cencora Inc (NYSE:COR) with a Sector Perform rating and a $330 price target, noting the company's pharma-aligned platform will benefit from specialty pharma growth. While recognizing the potential from specialty drugs and biosimilar introductions, the firm also highlighted Cencora's lower gross profit margin and anticipated headwinds from IRA negotiations affecting Part B drugs. This initiation comes as Cencora recently reported strong fiscal third-quarter 2026 results, surpassing expectations and raising its full-year profit outlook.
Walgreens, Petco and US Foods join SPS Commerce's initial 50 honorees
SPS Commerce announced its inaugural "Top Supply Chain Leaders" list, recognizing 50 operational leaders from across the U.S. and Canada for their innovation and excellence in supply chain management. Companies like Walgreens, US Foods, Petco, and Ace Hardware are among those honored for navigating disruptions and transforming operations with AI. This initiative aims to highlight the crucial role these leaders play in the evolving supply chain landscape.
Wealthfront Advisers LLC Sells 12,937 Shares of Stryker Corporation $SYK
Wealthfront Advisers LLC reduced its stake in Stryker Corporation by 25.5% in the second quarter, selling 12,937 shares and retaining 37,818 shares valued at approximately $11.9 million. Despite this, institutional investors collectively own 77.09% of Stryker, and analysts maintain a "Moderate Buy" rating with an average price target of $386.28. The company recently exceeded earnings expectations with $3.69 EPS and $6.59 billion in revenue, and declared a quarterly dividend of $0.88 per share.
Trust Co. of Vermont Purchases Shares of 12,339 Gilead Sciences, Inc. $GILD
Trust Co. of Vermont recently acquired a new stake of 12,339 shares in Gilead Sciences, Inc., valued at approximately $1.56 million. This move is part of broader institutional interest, with other major firms like Norges Bank and Boston Partners also significantly increasing their holdings in the biopharmaceutical company. Gilead Sciences reported stronger-than-expected Q2 earnings and revenue, and its stock has seen a 3.3% increase recently, trading at $143.44.
Cencora stock initiated at Sector Perform by RBC Capital with $330 target
RBC Capital has initiated coverage on Cencora Inc (NYSE:COR) with a Sector Perform rating and a price target of $330. The firm believes Cencora's pharma-aligned platform will benefit from specialty pharma growth but notes it lacks the high-growth, high-margin businesses seen in competitors. Despite potential headwinds from IRA negotiations on Part B drugs, biosimilar introductions are expected to drive margin accretion.
Cencora stock initiated at Sector Perform by RBC Capital with $330 target
RBC Capital initiated coverage on Cencora Inc (NYSE: COR) with a Sector Perform rating and a $330 price target, noting the company's pharma-aligned platform benefits from specialty pharma growth. Despite a 4% gross profit margin, RBC Capital expects specialty drugs to drive pharma spending to over 55% by 2028, with new cell and gene therapies contributing significantly. The firm anticipates headwinds from IRA negotiations on Part B drugs, but biosimilar introductions are expected to boost operating income.
Cencora stock initiated at Sector Perform by RBC Capital with $330 target
RBC Capital has initiated coverage on Cencora Inc (NYSE:COR) with a Sector Perform rating and a price target of $330.00, citing the company's pharma-aligned platform benefiting from growth in specialty pharma. While acknowledging the growth potential, RBC Capital expressed concerns about Cencora's gross profit margin and its lack of differentiated high-growth, high-margin businesses compared to competitors. Despite potential headwinds from IRA negotiations, the firm anticipates biosimilar introductions to boost operating income, and recent strong fiscal Q3 2026 results show Cencora surpassing expectations and raising its full-year profit outlook.
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Stock Price Cross Below Two Hundred Day Moving Average - Time to Sell?
Lakefront Biotherapeutics American Depositary Shares (NASDAQ: LKFT) recently saw its stock price fall below its 200-day moving average, trading at $27.99 against an average of $29.84. This occurred despite the company exceeding quarterly earnings and revenue expectations. Analysts generally hold a "Hold" rating for LKFT, with an average
How Should You Approach CVS Health Stock After Q2 Earnings?
CVS Health reported strong Q2 2026 results with significant revenue and adjusted operating income growth across all segments, leading management to raise its full-year outlook for adjusted EPS and cash flow. Despite the strong performance and outperformance against benchmarks and peers over the last 12 months, the stock saw a 5.1% dip after earnings. The company faces near-term challenges with its Caremark 340B business and potential membership declines but maintains an attractive valuation, suggesting existing shareholders might hold, while new investors may seek a better entry point.
GE HealthCare Appoints William Grogan as CFO Sept. 14 | GEHC Stock News
GE HealthCare (Nasdaq: GEHC) has announced the appointment of William (Bill) Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan joins from Xylem Inc., where he served as CFO and was instrumental in integrating a $7.5 billion acquisition, driving significant margin expansion, and optimizing capital deployment. His previous experience also includes over a decade at IDEX Corporation, where he repositioned its portfolio towards higher-growth markets and contributed to a doubling of the company's market capitalization.
Are BWMN, DV, BOW, INVE Obtaining Fair Deals for their Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws and breaches of fiduciary duties concerning the sales of Bowman Consulting Group Ltd. (BWMN), DoubleVerify Holdings, Inc. (DV), Bowhead Specialty Holdings Inc. (BOW), and Identiv, Inc. (INVE). The firm encourages shareholders to contact them to discuss their rights and options, as insiders may benefit disproportionately and terms might limit competing offers.
Kroger Health president Colleen Lindholz to keynote GLP-1 Shopper Summit
Colleen Lindholz, president of Kroger Health, will deliver the opening keynote at the inaugural GLP-1 Shopper Summit on November 12. Her keynote, "Reimagining Food as Health," will explore the intersection of food, nutrition, and healthcare, focusing on how retailers can facilitate healthier choices for consumers, especially with the growing adoption of GLP-1 medications. The summit will examine how these trends are reshaping shopper behavior and future growth strategies for retail and CPG industries.
Generation Income Properties : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
Generation Income Properties, Inc. (GIPR) released its quarterly report for the quarter ending June 30, 2026, detailing financial results, recent developments, and liquidity. The company reported net losses and outlined efforts to regain Nasdaq compliance, including a 1-for-10 reverse stock split and debt conversion agreements. It also provided an overview of its property portfolio, featuring creditworthy tenants and contractual rent growth.
Orca Investment Management LLC Makes New $6.66 Million Investment in Cardinal Health, Inc. $CAH
Orca Investment Management LLC has made a new $6.66 million investment in Cardinal Health (NYSE:CAH), purchasing 28,053 shares, which now represents 4.8% of its portfolio. The stock currently holds a consensus "Moderate Buy" rating with an average price target of $265.93, driven by favorable analyst sentiment. Cardinal Health recently exceeded EPS expectations and declared a quarterly dividend of $0.5158 per share.
LFG Wealth Partners LLC Makes New $1.70 Million Investment in Cigna Group $CI
LFG Wealth Partners LLC has made a new $1.70 million investment in Cigna Group (NYSE:CI), acquiring 6,150 shares during the second quarter. Cigna exceeded quarterly earnings expectations with $7.78 EPS and $70.04 billion in revenue, representing a 6.7% year-over-year increase. The company also declared a $1.56 quarterly dividend, and analysts maintain a "Moderate Buy" consensus with an average price target of $339.45.
Summit Global Investments Invests $1.16 Million in McKesson Corporation $MCK
Summit Global Investments recently acquired 1,533 shares of McKesson Corporation, valued at approximately $1.16 million, during the second quarter. This comes as McKesson exceeded quarterly earnings and revenue expectations, reporting $9.93 EPS and $105.38 billion in revenue. The company also increased its quarterly dividend from $0.82 to $0.94 per share, and analysts maintain a "Moderate Buy" rating with a target price of $977.
Handelsbanken Fonder AB Buys 3,280 Shares of LPL Financial Holdings Inc. $LPLA
Handelsbanken Fonder AB increased its stake in LPL Financial Holdings Inc. by 14.5% in Q2 2026, acquiring an additional 3,280 shares to own a total of 25,861 shares valued at $7.3 million. LPL Financial reported strong Q2 earnings with EPS of $5.84 and revenue of $5.19 billion, exceeding analyst expectations. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $406.69.
Cencora: Walgreens Volume Disruption Raises New Concern, but We Make No Changes for Now
Cencora disclosed that a portion of the volume it serviced for Walgreens began moving elsewhere starting July 1, causing a 4% drop in shares. Despite this new concern, the company reaffirmed its full-year EPS guidance of $17.75-$17.95, and Morningstar analysts are not yet making changes to their ratings. The article notes this development while referring to previous positive reports on Cencora's growth rebound and strong specialty assets.
Cencora Reports Walgreens Volume Transition, Confirms FY2026 Adjusted EPS Forecast
Cencora, Inc. has reported to the SEC that some Walgreens volume began transitioning out of the company on July 1, 2026, a move that was fully anticipated and does not affect their prime vendor agreement with Walgreens. The company reconfirmed its adjusted diluted EPS guidance for fiscal year 2026, setting it between $17.75 and $17.95. This disclosure emphasizes that while a portion of the business is shifting, the core relationship with Walgreens remains strong, and the financial outlook is unchanged.
Cencora says certain Walgreens volume moves outside company; reaffirms FY26 adjusted EPS $17.75-$17.95
Cencora announced that certain Walgreens volume began moving outside the company as of July 1, 2026. Despite this change, the prime vendor agreement with Walgreens, which represents the majority of Cencora's Walgreens business, remains unchanged. Cencora reaffirmed its fiscal year 2026 adjusted diluted EPS guidance of $17.75 to $17.95, stating this outcome was anticipated in their August 5, 2026 commentary.
Cencora maintains earnings guidance as some Walgreens volume moves away
Cencora (NYSE:COR) announced that some Walgreens volume previously serviced outside of its prime vendor agreement has shifted away, effective July 1. Despite this change, which was anticipated, the company reaffirmed its adjusted diluted earnings per share guidance of $17.75 to $17.95 for fiscal year 2026. Cencora also recently surpassed Wall Street forecasts with strong Q3 2026 results, reporting adjusted earnings of $4.48 per share and revenue of $84.8 billion, leading to a raised profit outlook for the full year.
Cencora maintains earnings guidance as some Walgreens volume moves away
Cencora announced that some Walgreens volume not covered by its prime vendor agreement has begun to shift away, a move it had anticipated. Despite this change, the company reaffirmed its adjusted diluted earnings per share guidance of $17.75 to $17.95 for fiscal year 2026. This follows Cencora's strong fiscal third-quarter performance, where it exceeded Wall Street forecasts and raised its full-year profit outlook.
J&J, Thinkbaby, Honest Co. Veterans Join Nice Advisory Team
The Nice Company has announced the formation of its Advisory Team, comprising industry veterans Kevin Brodwick (Thinksport/Thinksport), Guy Berechit (former J&J), and Christopher Gavigan (The Honest Company, Prima). This team brings extensive experience in CPG, entrepreneurship, and brand building to support The Nice Company's growth as it expands its retail presence and prepares to launch new products with redesigned packaging. The company, founded by Cisy Liu and Oscar Wang, aims to reimagine everyday household essentials with a focus on comfort, care, and thoughtful design.
Lederer & Associates Investment Counsel CA Takes Position in McDonald's Corporation $MCD
Lederer & Associates Investment Counsel CA recently acquired 6,128 shares of McDonald's Corporation (NYSE:MCD) valued at $1.66 million. Despite institutional ownership of over 70%, insiders have sold shares totaling $2.36 million in the last quarter. McDonald's reported strong quarterly earnings, beating EPS estimates, and declared a $1.86 quarterly dividend, yet faces challenges including slowing U.S. sales and competitive pressures.
Terrestrial Energy Q2 Earnings Call Highlights
Terrestrial Energy reported progress in its Q2 earnings across engineering, regulatory, supply-chain, and commercial development for its IMSR small modular reactor. The company outlined updated unit economics, increasing estimated lifetime revenue per unit to $2.7 billion and raising blended gross profit margin to 33%. Terrestrial Energy also highlighted its capital-light business model, regulatory approvals, and a new relationship with Riot Platforms to potentially supply 4 gigawatts of IMSR generation capacity for data centers.
Assenagon Asset Management S.A. Takes $16.71 Million Position in First American Financial Corporation $FAF
Assenagon Asset Management S.A. has initiated a significant position in First American Financial Corporation (NYSE:FAF), purchasing 243,675 shares valued at approximately $16.71 million. This move highlights institutional confidence, as the company recently exceeded Q2 earnings expectations with $2.08 EPS and $2.11 billion in revenue, driven by a 15% year-over-year growth. Analysts maintain a "Moderate Buy" rating with an average price target of $84.60, indicating further potential upside for the stock.
DataMeds AI renames pharmacy subsidiaries to Corexa
DataMeds AI, Inc. has rebranded its pharmacy and pharmacy hub subsidiaries to Corexa Pharmacy, LLC and Corexa Tech & Hub, LLC, respectively, under the newly named Corexa Health, LLC division. This restructuring aims to differentiate its pharmacy services from future healthcare offerings like telemedicine and diagnostic laboratory services. The company also highlighted its AI and blockchain platforms, planned acquisitions, and a partnership with National Football League Alumni Health.
First Trust Advisors LP Has $2.48 Million Position in Merit Medical Systems, Inc. $MMSI
First Trust Advisors LP significantly increased its stake in Merit Medical Systems, Inc. (MMSI) by 479.1% in the first quarter, now holding 35,907 shares valued at $2.48 million. Institutional investors collectively own 99.66% of MMSI, and analysts have a "Moderate Buy" consensus with an average price target of $100.30. Merit Medical reported strong quarterly earnings of $1.19 EPS, beating estimates, and revenue grew 9.5% year-over-year.
Edgestream Partners L.P. Has $101,000 Holdings in LegalZoom.com, Inc. $LZ
Edgestream Partners L.P. significantly reduced its stake in LegalZoom.com (NASDAQ:LZ) by 91.4% in the first quarter, selling 189,456 shares and retaining 17,736 shares valued at $101,000. Despite this, LegalZoom.com reported positive second-quarter results with a 6.6% year-over-year revenue increase to $205.3 million and EPS of $0.16, exceeding estimates. However, the company lowered its full-year 2026 revenue outlook, leading to cautious analyst sentiment and price target cuts.
FrontView Q2 2026 slides: diversification drives growth amid skepticism
FrontView REIT (NASDAQ:FVR) delivered strong second-quarter 2026 results, raising its full-year AFFO per share guidance to $1.32-$1.34, despite a 4.06% stock decline post-earnings. The company emphasized its diversified portfolio, disciplined capital allocation, and strong operational efficiency, including a low dividend payout ratio and conservative financial leverage. Management highlighted compelling valuation opportunities, suggesting significant upside potential compared to peers based on PEG ratios and implied capitalization rates, positioning FrontView for continued growth through strategic acquisitions and re-tenanting.
Earnings call transcript: FrontView tops Q2 2026 EPS forecast, shares fall
FrontView (FVR) reported stronger-than-expected Q2 2026 adjusted EPS of $0.03, beating analyst forecasts for a loss of $0.04, with revenue at $18.01 million. Despite the earnings beat and raised full-year AFFO per share guidance, the stock fell 3.69% in premarket trading, suggesting investors were focused on growth pace and capital deployment. The company highlighted strong portfolio performance, accretive capital deployment, and efficient operations as drivers for its improved outlook.
Sei Investments Co. Has $4.71 Million Stake in Capri Holdings Limited $CPRI
Sei Investments Co. significantly increased its stake in Capri Holdings Limited (CPRI) by 127% in the first quarter, now owning 267,471 shares valued at $4.71 million. Capri Holdings exceeded fiscal Q1 2027 earnings and revenue expectations, reporting adjusted EPS of $0.67 and revenue of $769 million, though revenue declined year-over-year. Despite institutional ownership of 84.34%, analysts maintain a cautious "Hold" rating with an average price target of $23.33, while the stock trades near its 52-week low.
Elf Beauty raises annual forecasts betting on international expansion drive
Elf Beauty has raised its annual sales and profit forecasts, driven by strong international expansion efforts in markets like the UK, Canada, and Germany, as American consumers continue to limit spending due to inflation. The company, known for its affordable products, also announced plans to launch its Rhode brand in 19 European countries and the Elf brand in Brazil through a partnership with Sephora, alongside a strategic price reduction on 10% of its portfolio. These initiatives are designed to boost volume and grow gross profit dollars over time, despite a slight dip in share prices in extended trading.
First Trust Advisors LP Purchases 44,713 Shares of Lantheus Holdings, Inc. $LNTH
First Trust Advisors LP significantly increased its stake in Lantheus Holdings, Inc. by 287.6% in Q1, acquiring 44,713 additional shares to hold a total of 60,258 shares valued at $4.57 million. This comes as Lantheus is set to be acquired by Curium for $102.50 per share in cash plus potential contingent value rights, with the transaction expected to close in the first half of 2027. Analyst sentiment for Lantheus is mixed, with a consensus "Hold" rating and an average price target of $108.11, while some shareholder law firms are investigating the fairness of the acquisition price.
Franklin Premier Income Trust Shares of Beneficial Interest Revenue Breakdown – BOATS:PPT
This article provides a revenue breakdown for Franklin Premier Income Trust Shares of Beneficial Interest (PPT). It highlights that the greatest contribution to its revenue came from the United States, which accounted for $24.95 million last year, up from $4.41 million the year before. The data is presented by source and by country, indicating key financial performance insights.
P&G is acquiring supplements maker Thorne, CEO Jejurikar tells CNBC
Procter & Gamble is set to announce its acquisition of supplements maker Thorne, as confirmed by P&G CEO Shailesh Jejurikar to CNBC. Jejurikar indicated that the acquisition price is favorable given Thorne's growth rates and aligns with industry benchmarks. This move follows earlier reports of other companies bidding for Thorne, which was previously valued at up to $4 billion.
Will this tax season be a boost or bust?
This article from the JPMorgan Chase Institute discusses the potential impacts of the upcoming tax season on U.S. households. It highlights that while tax refunds typically provide a significant cash infusion, delays in IRS processing and complex economic factors like inflation and expiring federal assistance could alter the usual boost. The article also notes that lower-income households and early filers, who rely heavily on refunds for necessities like healthcare, might be most affected.
E.l.f. Cosmetics and Bubble Team Up in New Hybrid Holy Grails Line
E.l.f. Cosmetics and Bubble have partnered to launch a limited-edition "Hybrid Holy Grails" collection featuring three innovative products. These products blend hero innovations from both brands, such as E.l.f.’s Bronzing Drops with Bubble’s Slam Dunk Hydrating Cream Moisturizer. The collaboration, available at Target and boots.com, stems from consumer demand and a shared brand ethos of community-driven disruption in the beauty industry.
Harris Teeter Adds Prescription Delivery via Instacart
Harris Teeter has partnered with Instacart to offer prescription delivery services, allowing customers to receive medications alongside their grocery orders. Shoppers need to enroll in the retailer's "My Prescriptions" program and set up Online Pay to use the service. This initiative expands delivery options for prescriptions and integrates health and wellness services with everyday shopping for Harris Teeter customers.
Janus Henderson Group PLC Sells 2,458 Shares of AutoZone, Inc. $AZO
Janus Henderson Group PLC reduced its stake in AutoZone, Inc. by 20% in the first quarter, selling 2,458 shares but still retaining 9,845 shares valued at $33.25 million. This comes as AutoZone reported strong quarterly results, beating earnings expectations and authorizing a $1.5 billion share repurchase program. Analysts maintain a "Moderate Buy" rating with a consensus price target significantly above the current share price.
Exelixis stock rating maintained at Market Outperform by Citizens
Citizens has maintained a Market Outperform rating and a $55.00 price target for Exelixis (NASDAQ:EXEL), noting that the stock appears undervalued according to InvestingPro analysis. The article also discusses the ongoing patent dispute between Exelixis and Handa Oncology regarding a new cabozantinib formulation and summarizes recent analyst updates and trial results for Exelixis from firms like H.C. Wainwright, Morgan Stanley, and UBS.
McGraw Hill, Inc. (NYSE:MH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
McGraw Hill, Inc. (NYSE:MH) has received a "Moderate Buy" consensus rating from fifteen brokerages, with an average 12-month price target of $18.47. Despite several analysts lowering their price targets, the company's recent quarterly EPS of $0.32 significantly beat the consensus estimate of $0.15 on revenues of $463.72 million. Shares opened at $10.96, with institutional investors recently modifying their holdings, including significant new positions acquired by Vanguard Group Inc. and Barclays PLC.
Canadian National won’t fight UP-NS merger under new deal
Canadian National (CN) has agreed not to oppose the proposed Union Pacific-Norfolk Southern (UP-NS) merger, contingent on Surface Transportation Board (STB) approval. This agreement would grant CN expanded access to shipper sites and Norfolk Southern’s ownership interests in Kansas City Terminal Railway Company and Terminal Railroad Association of St. Louis. While UP leadership views the merger as enhancing competitive options, BNSF Railway argues that the benefits CN gains could be achieved without the merger.
Philip Morris expands Colorado Zyn investment to $1.2 billion
Philip Morris International is increasing its investment in its Aurora, Colorado, Zyn nicotine pouch manufacturing facility to $1.2 billion by 2028, doubling its previous commitment. This expansion is driven by growing demand for smoke-free nicotine products and aims to bolster Zyn production amid increasing competition. The facility will also produce Zyn Ultra and serve international markets, supporting the company's broader transition away from traditional cigarettes.
Option Care Health Inc (OPCH) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Option Care Health Inc (OPCH), highlighting its major institutional investors and their proportional holdings. It also provides a breakdown of shareholder types, institutional shareholding trends over recent quarters, and lists related ETFs that include OPCH.
The Face Shop Enters 1,600 Walmart Stores
LG Household & Health Care's beauty brand, The Face Shop, has significantly expanded its U.S. presence by launching its 'Rice Water Bright' cleansing line in over 1,600 Walmart stores. This move follows strong online sales on Amazon and previous entries into Target, CVS, and Walgreens, solidifying its position as a leading K-beauty brand in the global market. The brand attributes its success to its popular Rice Water products, which reinterprets traditional Korean beauty methods and has gained recognition through strategic campaigns like the '1 Wipe Challenge' and promotion of the double cleansing method.
Arcus Biosciences Inc (RCUS) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Arcus Biosciences Inc (RCUS), identifying its major shareholders and institutional holdings. It provides a breakdown of ownership by entity type and lists changes in institutional shareholding over several quarters, highlighting key investors like Gilead Sciences, Inc. and BlackRock.
PNC Financial Services Group Inc. Cuts Position in Qnity Electronics, Inc. $Q
PNC Financial Services Group Inc. reduced its stake in Qnity Electronics, Inc. by 5.8% in the first quarter, selling over 19,000 shares. Despite this reduction, Qnity Electronics reported strong Q1 results, exceeding EPS estimates and showing a 17.6% increase in revenue. Analysts maintain a constructive outlook on the stock, with most issuing "Buy" or "Strong Buy" ratings and an average target price of $151.78.
